FFO
RCEL icon

Fortitude Family Office’s Avita Medical RCEL Stock Holding History

Fortitude Family Office’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$317 Sell
27
-42
-61% -$333 ﹤0.01% 2467
2026
Q2 		$285 Buy
+69
New +$298 ﹤0.01% 2065

Other funds holding RCEL

HCA
Harpswell Capital Advisors Yarmouth, Maine $152M AUM 8.39% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Fortitude Family Office's RCEL Position: Q3 2026 in Review

Fortitude Family Office reduced its Avita Medical (RCEL) stake by 61% in Q3 2026, selling an estimated $333 and leaving 27 shares worth $317. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

Fortitude Family Office first reported a position in RCEL in Q2 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.

  • Fortitude Family Office held 27 shares of Avita Medical worth $317 as of Q3 2026.
  • Fortitude Family Office sold 42 Avita Medical shares in Q3 2026, an estimated $333.
  • Avita Medical made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2467 holding.
  • Fortitude Family Office first reported a position in Avita Medical in Q2 2026 and has held it in 2 quarters since.
  • 4 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.